Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Ceritinib in anaplastic thyroid cancer (ATC) with ALK abnormalities. Khan, S. A., Bauman, J. E., Burtness, B., Frankel, A. E., Harper, J., Hughes, R. S., Kurian, P., Myers, L. L., Nedzi, L., Schwartz, D. L., Sumer, B. D., Truelson, J., Zhu, H. AMER SOC CLINICAL ONCOLOGY. 2015
View details for DOI 10.1200/jco.2015.33.15_suppl.tps6085
View details for Web of Science ID 000358036904811